PT Mandala Multifinance Tbk (IDX:MFIN)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,250,000	8,968,050	7,738,000	4,385,750	2,888,500	2,623,500
Market Cap Growth	82.61%	15.90%	76.44%	51.84%	10.10%	-23.85%
PE Ratio	5.24	17.39	18.30	6.66	5.95	15.04
PS Ratio	1.90	5.32	5.19	2.67	2.25	2.61
PB Ratio	0.85	2.30	2.28	1.36	1.05	1.12
P/FCF Ratio	-	-	30.45	10.99	-	2.50
P/OCF Ratio	-	-	23.90	9.83	-	2.45
Debt / Equity Ratio	0.74	0.61	0.87	0.94	0.83	0.70
Debt / FCF Ratio	-	-	11.66	7.61	-	1.55
Quick Ratio	2.76	19.88	25.77	26.16	23.09	22.87
Current Ratio	2.78	19.96	25.88	26.24	23.15	23.09
Asset Turnover	0.26	0.25	0.23	0.28	0.27	0.23
Return on Equity (ROE)	14.18%	14.14%	12.75%	21.95%	19.04%	7.56%
Return on Assets (ROA)	7.95%	7.73%	6.39%	11.05%	10.16%	3.90%
Earnings Yield	16.18%	5.75%	5.46%	15.02%	16.80%	6.65%
Earnings Yield	16.18%	5.75%	5.46%	15.02%	16.80%	6.65%
FCF Yield	-7.28%	-3.46%	3.28%	9.10%	-15.71%	39.93%
Dividend Yield	8.63%	3.55%	-	6.52%	7.64%	2.23%
Payout Ratio	59.06%	-	62.66%	29.38%	10.38%	45.59%
Buyback Yield / Dilution	15.42%	-0.07%	-	-	-	-
Total Shareholder Return	23.23%	3.47%	-	6.52%	7.64%	2.23%

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.